intern ad hoc work group expert cancer research met intern agenc research cancer iarc januari evalu data human experiment anim carcinogen chemic group chemic industri process
monograph chemic publish vol
iarc monograph evalu carcinogen risk chemic human
base evid human studi chemic industri process human carcinogen
chemic probabl carcinogen human although data consid adequ establish causal associ
reflect differ degre evid carcinogen within group chemic subdivid chemic exhibit high degre evid chemic exhibit lower degre
data remain chemic consid insuffici allow evalu carcinogen
report summar background purpos overal conclus work group
evid support evalu given appendix
examin effect digitali therapi postinfarct mortal throughout month month follow patient surviv acut myocardi infarct
follow patient die mortal
time hospit discharg patient take digitali
digitali treat patient older medic cardiac risk factor higher mortal rate throughout follow nondigitali treat patient
statist techniqu use adjust clinic imbal digitali treat patient nondigitali treat patient
surviv analysi patient util cox regress model digitali associ mortal risk identifi signific covari allow mortal could predict accur possibl
digitali therapi associ significantli increas postinfarct mortal risk adjust predictor covari rel risk confid interv less
find larg multicent studi suggest would prudent exercis caution use digitali postinfarct patient
congenit lipoid adren hyperplasia result sever impair steroid biosynthesi adren gland gonad manifest utero postnat
recent found mutat gene steroidogen acut regulatori protein four patient syndrom clear whether patient mutat substanti clinic variat patient
directli sequenc gene steroidogen acut regulatori protein patient congenit lipoid adren hyperplasia countri
identifi mutat confirm recreat express vector transfect cultur cell assay presenc activ steroidogen acut regulatori protein
fifteen differ mutat gene steroidogen acut regulatori protein found patient mutat found percent affect allel japanes korean patient mutat found percent affect allel palestinian patient
develop diagnost test eight mutat
thirteen mutat exon render steroidogen acut regulatori protein inact function assay
mutant amino acid replac capabl normal mitochondri process indic activ steroidogen acut regulatori protein associ transloc mitochondria
steroidogen cell lack protein retain low level steroidogenesi
explain secret steroid hormon ovari puberti affect cell accumul larg amount cholesterol ester
congenit lipoid adren hyperplasia phenotyp result two separ event initi genet loss steroidogenesi depend steroidogen acut regulatori protein subsequ loss steroidogenesi independ protein due cellular damag accumul cholesterol ester
fanconi anaemia fa autosom recess disord associ progress bone marrow failur varieti congenit abnorm predisposit acut myeloid leukaemia
cell fa patient show increas sensit bifunct dna crosslink agent diepoxybutan mitomycin characterist chromosom breakag
fa genet heterogen least five differ complement group fa fa describ
gene group fac clone function complement map chromosom ref gene complement group yet identifi
group gene faa recent map chromosom linkag analysi account fa case
narrow candid region linkag allel associ analysi isol gene mutat fa patient
gene encod protein amino acid signific homolog known protein may therefor repres new class gene associ prevent repair dna damag
concern possibl associ puva treatment increas risk noncutan cancer
alter risk cancer among person psoriasi also postul
test hypothesi nearli two decad prospect follow patient first began puva treatment psoriasi
compar risk noncutan cancer cohort expect base gener popul incid rate
overal risk noncutan cancer nearli ident expect gener popul
three separ site note signific increas thyroid cancer rr ci breast cancer rr ci central nervou system neoplasm rr ci
sinc howev risk central nervou system neoplasm elev rr ci rel risk breast cancer lower prior decad statist signific
associ higher level exposur puva risk cancer
detect signific increas risk lymphoma leukemia
studi support hypothesi long term puva treatment increas risk noncutan cancer
genet linkag studi place gene caus earli onset famili alzheim diseas fad chromosom ref
five mutat within presenilin ps gene map region recent report sever earli onset fad kindr
local ps gene kb region present structur gene evid altern splice describ six novel mutat earli onset fad pedigre alter residu conserv presenilin ps gene
european societi paediatr gasteroenterolog hepatolog nutrit espghan issu two set recommend treatment infant acut gastroenter
purpos multicentr studi perform european countri determin close current treatment compar espghan recommend
